Clinical CPD topic
Colorectal cancer: practise, reflect and record
Practise colorectal cancer through five clinical cases, review the explanations and build a professional learning record. Interpret a positive symptomatic FIT and select baseline distant-staging imaging.
First published · Sources checked
What you’ll work on
- Interpret a positive symptomatic FIT and select baseline distant-staging imaging.
- Choose primary curative treatment and assess the stated restriction on later-line pembrolizumab eligibility.
- Identify CEA as a marker used to monitor colorectal cancer recurrence.
Think through a clinical case
Decide how you would approach this case before opening the question session.
A 61-year-old presents in primary care with unexplained weight loss and altered bowel habit. Quantitative FIT is 14 micrograms haemoglobin per gram of faeces. Which action follows current NICE guidance?
A case from the UKMLA question bank. The session provides the answer and explanation after your attempt.
From a decision to a learning record
- Test your reasoning. Answer five questions from this topic’s clinical-content library.
- Explore the gaps. Review explanations and use Tutor to work through decisions that need more thought.
- Reflect on application. Describe what you learned and what you would change or investigate.
- Review your evidence. Confirm the activity and time spent, then retain or export your professional record.
Primary sources and further reading
Read the source in the same jurisdiction as your question session.
- 1 Recommendations | Quantitative faecal immunochemical testing to guide colorectal cancer pathway referral in primary care | Guidance | NICEUK source
- Recommendations organised by site of cancer | Suspected cancer: recognition and referral | Guidance | NICEUK source
- Greater Manchester Cancer Alliance: Colorectal pathway imaging guidelines (November 2024)UK source
- Recommendations | Colorectal cancer | Guidance | NICEUK source
- 1 Recommendations | Pembrolizumab for previously treated endometrial, biliary, colorectal, gastric or small intestine cancer with high microsatellite instability or mismatch repair deficiency | Guidance | NICEUK source